francesco soria
@frasor86
Followers
485
Following
2K
Statuses
391
Urologist, MD, FEBU. Division of Urology, University of the Studies of Torino, Turin, Italy. YAU full member. EAU NMIBC guidelines associate member
Joined August 2012
RT @UroDocAsh: @EurUrolOncol @frasor86 Great to see the multicenter validation of the IR NMIBC Scoring System, originally proposed by IBCG…
0
5
0
RT @EurUrolOncol: Clinical Validation of the Intermediate-risk Non–muscle-invasive Bladder Cancer Scoring System and Substratification Mode…
0
4
0
RT @SIU_Italia: 🎧 Ascoltalo su tutte le piattaforme podcast! 👨⚕️👩⚕️ @fotiosloupakis, medico oncologo, e @AurelianoStingi, biologo moleco…
0
5
0
RT @urotoday: 🎥 @frasor86 and @UroDocAsh discuss validating the IBCG scoring system for IR #BladderCancer, showing significant differences…
0
2
0
RT @UroMolinette: Some highlights from Urothelial Cancer Update 2024 Congress @paolo_gontero @frasor86 @unito @cittasalute_to ⤵️ https://t.…
0
6
0
RT @sproietti81: Let’ s start a super interesting meeting on urothelial cancer update organized by @paolo_gontero @frasor86 Superb tips &…
0
4
0
RT @UroMolinette: Urothelial Cancer Update 2024 🔬📍27 th of September 2024 - Turin. 📝 Registration for residents is free! Don't miss the opp…
0
6
0
RT @urotoday: 🎥 @frasor86 and @UroDocAsh discuss validating the IBCG scoring system for IR #BladderCancer, showing significant differences…
0
3
0
RT @paolo_gontero: Happy to share the link to the newly released summary of the NMIBC EAU guidelines! Thanks to @U…
0
26
0
RT @BladderCancerUS: Video in @Urotoday: @frasor86 discusses a study validating the @IBCG scoring system for intermediate-risk bladder canc…
0
2
0
@UroDocAsh @EurUrolOncol @paolo_gontero @jteoh_hk @BenjaminPradere @LAUrology_NL @UroMoschini @DrShariat @E_Laukhtina @IBCG_BladderCA @UrogerliMD @AndreaNecchi @MaxKates @EAU_Uroonco @siadaneshmand @joanfundi @garysteinbergmd @SpiessPhilippe @pcvblack @WesKassouf @SvatekRob @DrFelixGuerrero @PGrivasMDPhD @MattGalsky @MarekBabjuk @MRoupret @MariaJRibal @urogeek @UroCancerMD @LauraBukavinaMD @KKBree @evanguelosx @evacomperat Thank you @UroDocAsh and thank to all the @EAU_YAUrotheli group. Great team effort!
0
1
5
RT @UroDocAsh: Clinical Validation of the Intermediate-risk NMIBC Scoring System and Substratification Model Proposed by the IBCG (Internat…
0
31
0
RT @tompowles1: Perhaps the most important long-term bladder cancer data #ASCO24 Neoadjuvant Toripalimab & disitimab Vedotin in muscle inva…
0
99
0
RT @UroMolinette: A great honor today for our family at @UroMolinette to have Prof. David Penson @urogeek with us in Turin! 🇮🇹🇺🇸 @paolo_gon…
0
6
0
RT @siadaneshmand: Impressive results presented by @JoeJacobMD1 at #AUA2024 from SunRISE-1 trial showing 82.8% CR rate at anytime and 12mo…
0
34
0
RT @siadaneshmand: Good day for #bladdercancer BOND-3 results presented by @MarkTysonMD showing 75.2% CR at anytime for pts with BCG unresp…
0
10
0
RT @amassonlecomte: Best EAU guidelines 🇪🇺 crew with a magnificent view! Thank you @AFUrologie 🇫🇷for this incredible night in hôtel de Cril…
0
1
0
RT @tompowles1: A big day for bladder ca patients @US_FDA. Massive team effort. Platinum based chemo superseded at last. EV/pembro will tra…
0
114
0
RT @EurUrolOncol: Highlight: En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label…
0
25
0